CAS 1093659-90-5
:EZETIMIBE-D4
- (3R,4S)-3-[(3S)-3-(4-Fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-1-(2,3,5,6-tetradeuterio-4-fluorophenyl)azetidin-2-one
- (3R,4S)-1-(4-Fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-2-azetidinone-d4
- EZETIMIBE-D4
Ezetimibe-d4 [N-(4-fluoro-phenyl-d4)]
CAS:Reinheit:98 atom % DFarbe und Form:White SolidMolekulargewicht:413.46Ezetimibe-d4
CAS:Ezetimibe D4, a deuterium-labeled variant of Ezetimibe, functions as an inhibitor of Niemann-Pick C1-like1 (NPC1L1) and is recognized for its potent activationFormel:C24H21F2NO3Reinheit:98%Farbe und Form:White SolidMolekulargewicht:413.45(3R,4S)-3-[(3S)-3-(4-Fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-1-(2,3,5,6-tetradeuterio-4-fluorophenyl)azetidin-2-one
CAS:Kontrolliertes ProduktApplications Labelled Ezetimibe (E975000), an antihyperlipoproteinemic. A Cholesterol absorption inhibitor.
References van Heek, M., at al.: J. Pharmacol. Exp. Ther., 283, 157 (1997), van Heek, M., at al.: Brit. J. Pharmacol., 129, 1748 (2000)Formel:C242H4H17F2NO3Farbe und Form:NeatMolekulargewicht:413.45Ezetimibe-d4
CAS:Ezetimibe-d4 is a lipophilic, organo-metal chelator that has been used to assess the bioavailability of drugs in pharmacokinetic studies. Ezetimibe-d4 binds to the metal ion in the gastrointestinal tract and prevents it from being absorbed into the blood stream. The ability to bind with metals such as nickel and gallium makes it an ideal candidate for use in analytical methods such as LC-MS/MS. In addition, ezetimibe has been shown to be effective in reducing insulin sensitivity and may be a viable treatment for diabetes.
Formel:C24H21F2NO3Reinheit:Min. 95%Molekulargewicht:413.4 g/molRef: 3D-TTB65990
Ausgelaufenes produkt




